Legal Representation
Attorney
Paul C. Llewellyn
Application History
2 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 18, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 18, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of neurodevelopmental and neurodegenerative diseases and disorders, leukodystrophy, demyelinating diseases and disorders, and hypomyelinating diseases and disorders; Pharmaceutical preparations and substances for the treatment of glial fibrillary acidic protein-associated diseases and disorders, Alexander Disease, seizures, ataxia, motor function disorders, cognitive function disorders, dysphagia, and swallowing disorders; Pharmaceutical preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, neurologic, parasympathetic system, neuromuscular system, skeletomuscular system, central nervous system, epileptic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, metabolic, autoimmune and lymphoproliferative diseases and disorders; Pharmaceutical preparations containing zilganersen.
Class 044
Providing health information; providing healthcare information; medical information services provided via the Internet
Additional Information
Design Mark
The mark consists of two overlapping hexagon shapes formed by a series of irregular polygons with curved corners.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
044